Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Julphar
US Army
Argus Health
Fuji

Generated: June 24, 2019

DrugPatentWatch Database Preview

Litigation Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.
Biologic Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.

The biologic drugs covered by the patents cited in this case are ➤ Try a Free Trial , ➤ Try a Free Trial , and ➤ Try a Free Trial .

Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-10-28 10 Exhibit A infringes U.S. PatentNo. 6,673,337 (the “‘337 patent”) and U.S. Patent No. 6,641,834 (the “‘834 patent”) because…claimed in a patent or the use ofwhich is claimed in a patent before the expiration of such patent. 35 u.s.c…Act for a drug claimed in a patent orthe use of which is claimed in a patent if the purpose of such submission…ofthe ‘337 and ‘834 patents and, as such, its infringement ofthe ‘337 and ‘834 patents is willful. (Id. …on August 24, 2004. Allergan filed this suit for patent infringement pursuant to 35 U.S.C. § 271(€)(2). External link to document
2006-11-09 105 Motion to Amend/Correct filed in this case, one of the patents in suit, U.S. Patent No. 4,843,086, has expired The addition of …one of the patents in suit and to assert a defense and counterclaim that one of the patents in suit is…inequitable conduct The addition of a defense of patent expiration is plainly appropriate given that, since…26 September 2005 1:05-cv-00700-JJF Patent District Court, D. Delaware External link to document
2006-11-13 107 Amended Answer to Complaint Labs admits that United States Patent No. 4,843,086 (“the ‘086 patent"), entitled “Tetrahydro-Benzthiazoles…Products”), and (b) United States Patent No. 4,843,086 (“the ‘086 patent”) is invalid and not infringed …claim of the ‘086 patent; (d) The ‘812 patent be declared invalid; (e) The ‘086 patent be declared invalid… Labs admits that United States Patent No. 4,886,812 (“the ‘812 patent”), entitled Wl`etrahydro-Benzthiazoles…thereto is claimed by the ‘812 patent and if, and only if, the ‘812 patent is valid and enforceable Barr External link to document
2006-11-20 110 Letter asserted two patents against Barr in this litigation: U.S. Patent No. 4,843,086 (“the ’086 patent) and U.S….S. Patent No. 4,886,8l2 (“the ’SlZ patent”). Both the ’086 and ’SlZ patents are descendants of an original… States patent application that ultimately led to the issuance of a third patent, U.S. Patent No. 4,731,374…the ’374 patent”). The patents-in-suit also claim priority back to two original Gerrnan patent applications…filing of patent applications worldwide, the two German patent applications to which the patents~in-suit External link to document
2006-11-21 111 Exhibit A (Part 3) consuitation 253:13 consulted 250117 256:18 257:4,11 258:6,25 consulting 230:13 contact 133:5,13 156:12…the '086 patent, which 24 certainly not prepared to render in this 25 was the patent that intervened…appiication, the '94`7 18 uitimately ied to the ‘812 patent? 18 appiication, after you received this restriction…determine if there Was one, if you wish me to. 22 patent, would that be consistent with the 23 Q. So just…vague. 14 through 4 that are now in the '812 patent, if 15 A. Do you mean if 1 had submitted 15 you External link to document
2007-05-14 151 Appendix part 2 Were you involved in the substanct:? 2 5 7 l . l 5 1 153 1 763 Q. The contents uftlte applicatiun? 1 A. …possibilities are for R 1 ~~ this is the US patent 24 this patent application? 2 4 application - and you will…7 l l Q. For patent applications that you 11 : 2 B': 52 11 Q. Did you discuss patent 1 l : 1 3 : 5…Foreign Filing Text. 01 : 33 : 09 l 6 a patent or a license to a patent covering that 01 : 3 6 : 27 16 Q. So…you had drafted the original patent 02 : 3 8 : 4 7 14 inventor on the patent application? ' 02 : 4 2 External link to document
2007-08-16 171 Redacted Document quot;) and U.S. Patent No. 4,843,086 (whichl will refer to as “the °086 Patent” , and that the FDA approved…owner of U.S. Patent No. 4,866,812 (whichi will refer to as “the ‘812 Patent” or “the patent-in-suit"…and court eertitied” expert on patent matters before the Austrian Patent Court. I first was entered on …courses on patent law and procedure I am_ also a Direetor of the Diplorna Course on Patent Litigation…information to a European patent application that claimed priority &om two German patent applications was External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
Boehringer Ingelheim
Healthtrust
US Department of Justice
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.